As providers continue to adopt AI in droves, payers are under pressure to modernize their own administrative operations. Alaffia Health says its clinically grounded AI platform can help health plans reduce waste and risk, a bet investors backed this week with a $55 million Series B funding round. The post Alaffia Health Snags $55M for…
Included Health is launching an alternative health plan centered on primary care, AI support, price transparency and easier navigation. The post Included Health Launches Alternative Plan Design for Employers appeared first on MedCity News.
A monthly injectable GLP-1 drug from Pfizer’s $10 billion Metsera acquisition is now on track for a Phase 3 program spanning 10 pivotal studies this year. While Pfizer’s pipeline spans internally developed and in-licensed assets for other targets, the pharma company says the Metsera drug is the foundation for its obesity strategy pursuing monotherapies and…
We’re losing the patching battle and therefore the ransomware war. Here’s how healthcare can change its perspective, improve patching, and better block ransomware pathways. The post Stop Treating Patches Like They’re Riskier Than Ransomware appeared first on MedCity News.
AI and analytics offer a path forward that prioritizes smarter workflows, coordination between teams, and better visibility into system performance. The organizations best positioned will be the ones that invest in responsible innovation, interoperability, and tools that make a difference in their daily work. The post How AI and Predictive Analytics Will Shape EMS, Fire,…
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets. The post The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown…
WellTheory launched a postpartum program to help women manage autoimmune symptoms triggered by hormonal changes after childbirth. The post WellTheory Introduces Autoimmune Postpartum Program appeared first on MedCity News.
The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options. The…
In this episode, we’re joined by Anna Jeter, co-founder and chief regulatory officer of AOA Dx. We dive into AOA Dx’s recent report on women’s health exits. The post MedCity FemFwd: Why Women’s Health Is a Scalable Sector appeared first on MedCity News.
We cannot wait for CMS to hand us perfect blueprints for rehab. The time is now for rehab leaders to define what optimized care looks like, build these pathways using evidence and outcomes data, and then aggressively demonstrate that our services are the most effective way to align with the new strategic direction of healthcare….